Prosecution Insights
Prosecution Insights
10 pending office actions • 9 art units • 10 examiners • 0 of 10 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 10 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 10 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (10%) |
| §103 only | 1 (10%) |
| Double-patenting + other | 2 (20%) |
| Multi-statute (no §101) | 6 (60%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| COLEMAN, BRENDA LIBBY | 1 | 74.6% | +15.6% |
| LIU, XIAO | 1 | 88.6% | +12.0% |
| WHITE, DAWANNA SHAR-DAY | 1 | 62.3% | +20.3% |
| LU, CHENG | 1 | 53.7% | +66.2% |
| COLENA, TRACY CHING-TIAN | 1 | 83.3% | +26.2% |
| ALLEN, MICHAEL D | 1 | 32.4% | +49.2% |
| CHANDRA, GYAN | 1 | 71.3% | +27.4% |
| LIPPERT, JOHN WILLIAM | 1 | 56.6% | +41.3% |
| AEDER, SEAN E | 1 | 56.9% | +19.9% |
| SHUPE, ELIZABETH A | 1 | 65.7% | +46.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 7 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17797644 | METHODS FOR THE TREATMENT OF HUNTER SYNDROME | CHANDRA, GYAN | 37d overdue |
| 18701573 | MICROGLIAL CELL MORPHOMETRY | LIU, XIAO | 19d overdue |
| 18646220 | CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROPYRIDO [3,2-B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDE | COLEMAN, BRENDA LIBBY | 16d overdue |
| 18248818 | METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA | COLENA, TRACY CHING-TIAN | 15d overdue |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | AEDER, SEAN E | 15d overdue |
| 17819182 | ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS | ALLEN, MICHAEL D | 8d overdue |
| 18276823 | ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF | LU, CHENG | 46d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17178595 | ANTI-HER2 POLYPEPTIDES AND METHODS OF USE THEREOF | SHUPE, ELIZABETH A | 79d overdue |
| 17797644 | METHODS FOR THE TREATMENT OF HUNTER SYNDROME | CHANDRA, GYAN | 37d overdue |
| 18701573 | MICROGLIAL CELL MORPHOMETRY | LIU, XIAO | 19d overdue |
| 18646220 | CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROPYRIDO [3,2-B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDE | COLEMAN, BRENDA LIBBY | 16d overdue |
| 18248818 | METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA | COLENA, TRACY CHING-TIAN | 15d overdue |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | AEDER, SEAN E | 15d overdue |
| 17819182 | ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS | ALLEN, MICHAEL D | 8d overdue |
| 18276823 | ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF | LU, CHENG | 46d |
| Art Unit | Apps |
|---|---|
| 1642 | 2 |
| 1624 | 1 |
| 2664 | 1 |
| 1627 | 1 |
| 1797 | 1 |
| 1671 | 1 |
| 1674 | 1 |
| 1615 | 1 |
| 1643 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18646220 | CRYSTALLINE FORMS OF (S)-5-BENZYL-N-(5-METHYL-4-OXO-2,3,4,5-TETRAHYDROPYRIDO [3,2-B][1,4]OXAZEPIN-3-YL)-4H-1,2,4-TRIAZOLE-3-CARBOXAMIDE | COLEMAN, BRENDA LIBBY | 1624 | §102§103 | Final Rejection | 16d overdue | Pending | Apr 25, 2024 |
| 18701573 | MICROGLIAL CELL MORPHOMETRY | LIU, XIAO | 2664 | §103§112 | Non-Final OA | 19d overdue | Pending | Apr 15, 2024 |
| 18288734 | METHODS FOR TREATING AND MONITORING PARKINSON'S DISEASE | WHITE, DAWANNA SHAR-DAY | 1627 | §102§103DP | Non-Final OA | 83d | Pending | Oct 27, 2023 |
| 18276823 | ANTI-TRANSFERRIN RECEPTOR FUSION PROTEINS AND METHODS OF USE THEREOF | LU, CHENG | 1642 | §102§103§112Other | Non-Final OA | 46d | Pending | Aug 10, 2023 |
| 18248818 | METHODS FOR TREATING AND MONITORING FRONTOTEMPORAL DEMENTIA | COLENA, TRACY CHING-TIAN | 1797 | §101§103 | Non-Final OA | 15d overdue | Pending | Apr 12, 2023 |
| 17819182 | ENGINEERED ANTI-HER2 BISPECIFIC PROTEINS | ALLEN, MICHAEL D | 1671 | §102§103§112 | Non-Final OA | 8d overdue | Pending | Aug 11, 2022 |
| 17797644 | METHODS FOR THE TREATMENT OF HUNTER SYNDROME | CHANDRA, GYAN | 1674 | §102§103§112Other | Final Rejection | 37d overdue | Pending | Aug 04, 2022 |
| 17614842 | MODIFIED RELEASE FORMULATION OF A PYRIMIDINYLAMINO-PYRAZOLE COMPOUND, AND METHODS OF TREATMENT | LIPPERT, JOHN WILLIAM | 1615 | §103 | Final Rejection | 62d | Pending | Nov 29, 2021 |
| 17296506 | METHODS FOR TREATING DYSREGULATED LIPID METABOLISM | AEDER, SEAN E | 1642 | §103§112 | Non-Final OA | 15d overdue | Pending | May 24, 2021 |
| 17178595 | ANTI-HER2 POLYPEPTIDES AND METHODS OF USE THEREOF | SHUPE, ELIZABETH A | 1643 | §103DP | Non-Final OA | 79d overdue | Pending | Feb 18, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial